Indeed, LGR5 is highly expressed in aggressive Ewing sarcoma and CSCs and the binding of RSPO-2 on LGR5 was able to potentiate Wnt3a-induced canonical Wnt signaling. Here, WNT3A is linked to Ewing sarcoma.